Glenmark Life Sciences Limited Financial Overview
Glenmark Life Sciences Limited's market cap is currently ₹111.96B. The company's EPS TTM is ₹10.6; its P/E ratio is 21.09; and it has a dividend yield of 0.56%. Glenmark Life Sciences Limited is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
